Cargando…
Alimentary and Pharmaceutical Approach to Natural Antimicrobials against Clostridioides difficile Gastrointestinal Infection
Incidence of Clostridioides difficile infection (CDI) has been increasing in recent decades due to different factors, namely (i) extended use of broad-spectrum antibiotics, (ii) transmission within asymptomatic and susceptible patients, and (iii) unbalanced gastrointestinal microbiome and collateral...
Autores principales: | Tortajada-Girbés, Miguel, Rivas, Alejandro, Hernández, Manuel, González, Ana, Ferrús, Maria A., Pina-Pérez, Maria C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159093/ https://www.ncbi.nlm.nih.gov/pubmed/34069413 http://dx.doi.org/10.3390/foods10051124 |
Ejemplares similares
-
An Atypical Case of Monomicrobial Clostridioides difficile Septicemia With No Gastrointestinal Manifestations
por: Wang, Liqian, et al.
Publicado: (2022) -
Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin
por: Maaß, Sandra, et al.
Publicado: (2021) -
Evolution of clinical guidelines for antimicrobial management of Clostridioides difficile infection
por: Chaar, Abdelkader, et al.
Publicado: (2021) -
Iron Effects on Clostridioides difficile Toxin Production and Antimicrobial Susceptibilities
por: Yamaki, Jason, et al.
Publicado: (2022) -
Prevalence of Clostridioides difficile and Other Gastrointestinal Pathogens in Patients with COVID-19
por: Laszkowska, Monika, et al.
Publicado: (2021)